<DOC>
	<DOC>NCT00888784</DOC>
	<brief_summary>The investigators conducted a randomized, controlled trial (RCT) to study the efficacy of beta blockers versus endoscopic cyanoacrylate injection in the prevention of gastric variceal (GOV2 or IGV1) rebleeding and improvement in survival.</brief_summary>
	<brief_title>Secondary Prophylaxis Gastric Variceal Bleed</brief_title>
	<detailed_description />
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Patients with GOV2 without esophageal varix or IGV1, who had bled from GV were included Presence of esophageal varix GOV2 with GOV1; contraindications to betablocker therapy and cyanoacrylate injection Prior injection of cyanoacrylate or sclerotherapy for GV or GV ligation, transjugular intrahepatic portosystemic shunt, balloonoccluded retrograde transvenous obliteration, balloonoccluded endoscopic injection sclerotherapy of GV, shunt operation for prevention of rebleeding from GV Patients already on betablocker or nitrates Undetermined origin of bleeding from esophageal varix or gastric varix Hepatic encephalopathy grade III/IV Hepatorenal syndrome Hepatocellular carcinoma Presence of deep jaundice (serum bilirubin &gt; 10 mg/dl) Uremia Cerebrovascular accident Cardiorespiratory failure Pregnancy or patients not giving informed consent for endoscopic procedures</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>